Responses
Abstracts Accepted for Publication
SLE, Sjögren's and APS - treatment
AB0446 Additive inhibition of interferons, b and t cell activation and tfh-related cytokine cxcl13 by leflunomide and hydroxychloroquine supports rationale for combination therapy in pss patients
Compose a Response to This Article
Other responses
No responses have been published for this article.